210 related articles for article (PubMed ID: 30418577)
1. A rapid and non-pathogenic assay for association of Mycobacterium tuberculosis gyrBA mutations and fluoroquinolone resistance using recombinant Mycobacterium smegmatis.
Yoshida M; Nakata N; Miyamoto Y; Fukano H; Ato M; Hoshino Y
FEMS Microbiol Lett; 2018 Dec; 365(23):. PubMed ID: 30418577
[TBL] [Abstract][Full Text] [Related]
2. WQ-3810: A new fluoroquinolone with a high potential against fluoroquinolone-resistant Mycobacterium tuberculosis.
Ouchi Y; Mukai T; Koide K; Yamaguchi T; Park JH; Kim H; Yokoyama K; Tamaru A; Gordon SV; Nakajima C; Suzuki Y
Tuberculosis (Edinb); 2020 Jan; 120():101891. PubMed ID: 31778929
[TBL] [Abstract][Full Text] [Related]
3. Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis.
Luo T; Yuan J; Peng X; Yang G; Mi Y; Sun C; Wang C; Zhang C; Bao L
J Antimicrob Chemother; 2017 Jul; 72(7):1893-1900. PubMed ID: 28387828
[TBL] [Abstract][Full Text] [Related]
4. Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium.
Thapa J; Chizimu JY; Kitamura S; Akapelwa ML; Suwanthada P; Miura N; Toyting J; Nishimura T; Hasegawa N; Nishiuchi Y; Gordon SV; Nakajima C; Suzuki Y
Microbiol Spectr; 2023 Jun; 11(3):e0508822. PubMed ID: 37067420
[TBL] [Abstract][Full Text] [Related]
5. The Molecular Genetics of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
Mayer C; Takiff H
Microbiol Spectr; 2014 Aug; 2(4):MGM2-0009-2013. PubMed ID: 26104201
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis.
Qiao M; Ren W; Guo H; Huo F; Shang Y; Wang Y; Gao M; Pang Y
Int J Infect Dis; 2021 May; 106():295-299. PubMed ID: 33864922
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
[TBL] [Abstract][Full Text] [Related]
8. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
Pantel A; Petrella S; Matrat S; Brossier F; Bastian S; Reitter D; Jarlier V; Mayer C; Aubry A
Antimicrob Agents Chemother; 2011 Oct; 55(10):4524-9. PubMed ID: 21768507
[TBL] [Abstract][Full Text] [Related]
9. Characterization of gyrA and gyrB mutations associated with fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Morocco.
Chaoui I; Oudghiri A; El Mzibri M
J Glob Antimicrob Resist; 2018 Mar; 12():171-174. PubMed ID: 29033301
[TBL] [Abstract][Full Text] [Related]
10. Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis.
Pantel A; Petrella S; Veziris N; Matrat S; Bouige A; Ferrand H; Sougakoff W; Mayer C; Aubry A
J Antimicrob Chemother; 2016 Sep; 71(9):2428-31. PubMed ID: 27234461
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis.
Brandis G; Pietsch F; Alemayehu R; Hughes D
J Antimicrob Chemother; 2015 Mar; 70(3):680-5. PubMed ID: 25362573
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
[TBL] [Abstract][Full Text] [Related]
13. Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.
Pantel A; Petrella S; Veziris N; Brossier F; Bastian S; Jarlier V; Mayer C; Aubry A
Antimicrob Agents Chemother; 2012 Apr; 56(4):1990-6. PubMed ID: 22290942
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.
Bernard C; Veziris N; Brossier F; Sougakoff W; Jarlier V; Robert J; Aubry A
Antimicrob Agents Chemother; 2015 Mar; 59(3):1519-24. PubMed ID: 25534742
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel resistance-associated mutations and discrimination within whole-genome sequences of fluoroquinolone-resistant
Chong Y; Li X; Long Y; Pei S; Ren Q; Feng F; Zhang H
Microbiol Spectr; 2024 Jun; 12(6):e0393023. PubMed ID: 38687077
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones.
Matrat S; Veziris N; Mayer C; Jarlier V; Truffot-Pernot C; Camuset J; Bouvet E; Cambau E; Aubry A
Antimicrob Agents Chemother; 2006 Dec; 50(12):4170-3. PubMed ID: 17015625
[TBL] [Abstract][Full Text] [Related]
17. Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance.
Yokoyama K; Kim H; Mukai T; Matsuoka M; Nakajima C; Suzuki Y
PLoS Negl Trop Dis; 2012; 6(10):e1838. PubMed ID: 23071850
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of fluoroquinolone monoresistance in Mycobacterium tuberculosis.
Lu J; Liu M; Wang Y; Pang Y; Zhao Z
FEMS Microbiol Lett; 2014 Apr; 353(1):40-8. PubMed ID: 24822277
[TBL] [Abstract][Full Text] [Related]
19. Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
Avalos E; Catanzaro D; Catanzaro A; Ganiats T; Brodine S; Alcaraz J; Rodwell T
PLoS One; 2015; 10(3):e0120470. PubMed ID: 25816236
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a line probe assay for the rapid detection of gyrA mutations associated with fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis.
Ando H; Mitarai S; Kondo Y; Suetake T; Kato S; Mori T; Kirikae T
J Med Microbiol; 2011 Feb; 60(Pt 2):184-188. PubMed ID: 21051549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
